THE PROBENECID TEST IN PARKINSON'S DISEASE
- 1 October 1972
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 300 (7783), 926-927
- https://doi.org/10.1016/s0140-6736(72)92566-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measuresNeuropharmacology, 1972
- PROBENECID TEST IN PARKINSON'S DISEASEThe Lancet, 1971
- PREDICTING RESPONSE TO LEVODOPAThe Lancet, 1971
- Rapid elevation of biogenic amine metabolites in human CSF following probenecidLife Sciences, 1970
- The effect of L-Dopa on monoamine metabolites in Parkinson's diseaseCellular and Molecular Life Sciences, 1970
- Measurement of acid monoamine metabolites in human and animal cerebrospinal fluidJournal of Neurochemistry, 1968
- Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's DiseaseNature, 1968
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecidLife Sciences, 1966
- On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric methodLife Sciences, 1963